1 / 22

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez. Diabetes and Other Carbohydrate Disorders. Hyperglycemia. Increase in plasma glucose levels due to hormone imbalance Healthy patients Insulin is secreted by the β cells of the pancreatic islets of Langerhans Reference Range

khalil
Télécharger la présentation

MLAB 2401: Clinical Chemistry Keri Brophy-Martinez

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MLAB 2401: Clinical ChemistryKeri Brophy-Martinez Diabetes and Other Carbohydrate Disorders

  2. Hyperglycemia • Increase in plasma glucose levels due to hormone imbalance • Healthy patients • Insulin is secreted by the β cells of the pancreatic islets of Langerhans • Reference Range • Increased plasma glucose: • > 110 mg / dl • Glucose reference range: • 74 - 106 mg / dl

  3. Effects of Hyperglycemia • Immediate Effects • Increased extracellular osmotic pressure • The increased glucose in plasma pulls water out of cells • Results in dehydration • Acidosis - metabolic acidosis. • May result • If the patient’s cells are not able to take in glucose, they may begin to convert fats to fatty acids, which then become keto acids.

  4. Effects of Hyperglycemia: Long term • Physiological • Heart attacks/strokes, Diabetic retinopathy(Blindness), kidney failure, neurologic defects, susceptibility to infections • Chemical • Glycosylated hemoglobin • the formation of glycosylated hemoglobin is the result of prolonged elevation of plasma glucose.

  5. Diabetes • Characterized by hyperglycemia • Disorders differ in etiology, symptoms and consequences • Lab’s role • Assist in diagnosis of the disease • Identification of the disorder • Assessment of progression of tissue damage

  6. Physiologic abnormalities of diabetes • Hyperglycemia • increase blood glucose. • Doesn’t matter how the glucose is derived - diet, fat metabolism, protein destruction/wasting • Ketosis • from fat metabolism, ketonemia, ketonuria • Hyperlipidemia -increase blood lipids from faulty glucose metabolism. • Decrease blood pH - metabolic acidosis • Urine abnormalities • Glycosuria– glucose present • Polyuria - increase in urine volume • Loss of electrolytes - washing out with the urine

  7. Diabetes • World Health Organization (WHO) and American Diabetes Association (ADA) recommends four categories of diabetes: • Type 1 diabetes • Most severe and potentially lethal • Type 2 diabetes • Other (secondary diabetes) • Gestational diabetes mellitus (GDM)

  8. Type 1 Diabetes • Insulin dependent diabetes mellitus ( IDDM ) • 5-10 % of diabetes cases • Demographics • Non-Hispanic Whites/ Non-Hispanic Blacks • Children & adolescents • Pathology • Disease triggered by viral illness or environmental factors that destroys beta cells in pancreas. • Absolute Insulin deficiency • Defect in secretion, production or action or all • Autoimmune destruction of islet beta – cells in pancreas • Auto-antibodies are present

  9. Type 1 Diabetes • Clinical Symptoms • CLASSIC TRIAD • Polyphagia(increased food uptake) • Polydipsia (thirst) • Polyuria( increased urine production) • Other symptoms • Mental confusion • Rapid weight loss • Hyperventilation • Diabetic ketoacidosis

  10. Laboratory Findings • Hyperglycemia- plasma levels > 110 mg/dL • Glucosuria- plasma glucose > 180 mg / dl • Decreased insulin • Increased glucagon • Stimulation causes • Gluconeogenesis • Lipolysis (breakdown of fat produces ketones) • Ketoacidosis • Decreased blood pH ( acidosis ) •  Sodium …  Potassium …  CO2

  11. Type II Diabetes • Non – Insulin Dependent Diabetes Mellitus( NIDDM ) • Most common form of diabetes • Demographics • Adult onset • Patients usually > 20 years old • American Indians and non-Hispanic blacks

  12. Type II Diabetes: Pathology • Develops gradually • Disorder in insulin resistance and relative deficiency of insulin • Plasma glucose is unable to enter cells • Contributory factors • Obesity • Lack of exercise • Diet • Genetics • Drugs, such as diuretics, psychoactive drugs • Increases in hormones that inhibit/antagonize insulin (GH & cortisol)

  13. Laboratory Findings • Hyperglycemia • Glucosuria • Insulin is present • Glucagon is notelevated • No lipolysis and noketoacidosis • Excess glucose is converted to triglycerides (  plasma triglycerides ) • Normal / Increased Na / K • Increased BUN & Creatinine ( Decreased renal function ) • Hyperosmolar plasma from hyperglycemia

  14. Other (SecondaryDiabetes) • Genetic defects of beta cell function • Genetic defects in insulin action • Genetic syndromes • Pancreatic disease • Endocrinopathies • Drug or chemical induced

  15. Gestational Diabetes • Glucose intolerance associated with pregnancy’s hormonal and metabolic changes • Mothers usually return to normal after pregnancy, but with increased risk for diabetes later on in life • Infants are at increased risk for respiratory complications and hypoglycemia after birth

  16. Criteria for Diagnosis of Diabetes • Symptoms of diabetes plus random plasma glucose concentration > 200 mg/dL. Random is defined as any time of day without regard to time OR • Fasting plasma glucose > 126 mg/dL. Fasting is defined as no caloric intake for at least 8 hours. OR • 2-Hour postprandial glucose > 200 mg/dL during an oral glucose tolerance test OR 4. A HgbA1C > 6.5%, confirmed on repeat measurement • Side notes • Glucose tolerance testing ( GTT ) is considered to be of limited additional use in the diagnosis of diabetes and not recommended, do 2 hour pp test as stated above. • Urine glucose testing is also not recommended in diabetes diagnosis

  17. Hypoglycemia • Plasma glucose level falls below 60 mg/dL • Glucagon is released when plasma glucose is < 70 mg / dL to inhibit insulin • Epinephrine, cortisol, and growth hormone released from adrenal gland to increase glucose metabolism and inhibit insulin • Treatment • Varies with cause. Generally, hypoglycemia is treated with small, frequent meals, (5-6 / day) low in carbohydrates, high in protein

  18. Hypoglycemia Symptoms Lab Findings Decreased plasma glucose • Increased hunger • Sweating • Nausea • Vomiting • Dizziness • Shaking • Blurring of speech and sight • Mental confusion • Whipple’s Triad • Symptoms of hypoglycemia • Low plasma glucose at time of symptoms • Alleviation of symptoms with glucose ingestion

  19. Hypoglycemia • Causes of: • Reactive • Insulin overdose in diabetics • Ethanol ingestion • Fasting • Insulin-producing tumors • Hepatic dysfunction • Sepsis

  20. Galactosemia • Resulting from : • Galactose 1, phosphate uridyl transferase deficiency • enzyme that converts galactose to glucose, patients cannot change either galactose or lactose into glucose. • results in galactosemia (galactose in blood) • Effects: • Can lead to mental retardation, cataracts, death • check children < 3 yrs for reducing substances

  21. References • Bishop, M., Fody, E., & Schoeff, l. (2010). Clinical Chemistry: Techniques, principles, Correlations. Baltimore: WoltersKluwer Lippincott Williams & Wilkins. • Centers for Disease Control. (2012). Diabetes Public Health Resource. Retrieved from http://www.cdc.gov/diabetes/pubs/factsheet11.htm • Sunheimer, R., & Graves, L. (2010). Clinical Laboratory Chemistry. Upper Saddle River: Pearson . • http://crossfitovercome.com/2011/12/29/diabetes-primer/

More Related